Trial Profile
Biweekly docetaxel (Taxotere) in combination with capecitabine (Xeloda) as first-line treatment in patients with advanced gastric cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms GAST-TaxXel
- 26 May 2008 New trial record.